BB&T Securities’s ChemoCentryx, Inc. CCXI Stock Holding History

BB&T Securities’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$887K	Sell	130,827 -8,000	-6%	-$60K	0.01%	854
2019 Q2	$1.29M	Buy	138,827 +4,000	+3%	+$46.3K	0.01%	724
2019 Q1	$1.87M	Buy	134,827 +20,000	+17%	+$229K	0.02%	598
2018 Q4	$1.25M	Buy	114,827 +16,327	+17%	+$172K	0.01%	676
2018 Q3	$1.25M	Hold	98,500	–	–	0.01%	745
2018 Q2	$1.3M	Buy	98,500 +15,000	+18%	+$179K	0.01%	719
2018 Q1	$1.14M	Hold	83,500	–	–	0.01%	737
2017 Q4	$496K	Hold	83,500	–	–	0.01%	997
2017 Q3	$619K	Hold	83,500	–	–	0.01%	912
2017 Q2	$781K	Buy	+83,500	New	+$613K	0.01%	830

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BB&T Securities's CCXI Position: Q3 2019 in Review

BB&T Securities reduced its ChemoCentryx, Inc. (CCXI) stake by 5.8% in Q3 2019, selling an estimated $60K and leaving 130,827 shares worth $887K. The position accounts for 0.01% of the portfolio, ranked #854.

BB&T Securities first reported a position in CCXI in Q2 2017 and has held it in 10 quarters since. The position peaked at $1.87M in Q1 2019. 100 funds tracked by Wall St. Rank hold CCXI as of Q3 2019.

BB&T Securities held 130,827 shares of ChemoCentryx, Inc. worth $887K as of Q3 2019.
BB&T Securities sold 8,000 ChemoCentryx, Inc. shares in Q3 2019, an estimated $60K.
ChemoCentryx, Inc. made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #854 holding.
BB&T Securities first reported a position in ChemoCentryx, Inc. in Q2 2017 and has held it in 10 quarters since.
BB&T Securities's ChemoCentryx, Inc. position peaked at $1.87M in Q1 2019.
100 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.